Insulin Pumps Global Market – Forecast To 2028

Publishing Date :	October, 2021
Report Code :	HCMD0163
Price:	Single license $4,950 Site license $6,750 Global license $9,000

Note: The report would be dispatched after confirmation of payment

Insulin pumps are medical devices used for administering insulin in an automated, controlled, and precise manner. These devices are used in the treatment of diabetes mellitus know as continuous subcutaneous insulin infusion (CSII), these insulin systems help in avoiding medical errors which would lead to serious life-threatening circumstances or even sometimes to the death of a patient.

According to IQ4I analysis, the insulin pumps global market is expected to grow at a high single digit CAGR from 2021 to 2028 to reach $6,412.9 million by 2028. The insulin pumps market is segmented based on products, applications, pump utility, end-users and geography. The insulin pumps products market is segmented into insulin pumps and consumables, among them, insulin pumps held the largest share of the market in 2021 and are expected to grow at high single digit CAGR from 2021 to 2028. Insulin pumps are further sub-segmented into tethered insulin pumps and patch insulin pumps, among which the patch pump accounted for the largest share in 2021 and is expected to grow at high single digit CAGR from 2021 to 2028, the tethered pump market is expected to grow at strong CAGR from 2021 to 2028. The applications market is segmented into type 1 diabetes and type 2 diabetes, among them, the type 1 diabetes segment held the largest share in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028. The market based on pump utility is segmented into disposable pumps and durable pumps, among which durable pumps command the largest revenue in 2021, the disposable pump segment is expected to grow at high single digit CAGR from 2021 to 2028. The disposable pump market is further sub-segmented into fully disposable and partially disposable pumps, among which, the fully disposable segment commanded the largest revenue in 2021. The end-users market is classified into hospitals, ambulatory surgical centers, homecare and others. Among them, home healthcare commanded the largest share in 2021 and is expected to be the fastest-growing segment with high single digit CAGR from 2021 to 2028.

Geographically, North America is the largest market, with a share followed by Europe and the Asia Pacific. The APAC region is the fastest-growing region and is expected to grow at low teen CAGR from 2021 to 2028 presenting an array of growth opportunities and is likely to get the attention of new investors in the insulin pumps market. Growth in the Asian market is attributed to the rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.

The insulin pumps market is expected to grow at high single digit CAGR from 2021 to 2028. An increase in the prevalence of diabetes, advantages of insulin pumps in the home care setting, and increasing distribution agreements, partnerships and collaboration activities, are the factors driving the market growth. The increasing product approvals and market expansion in emerging nations are expected to offer potential opportunities.

However, various factors like high cost, inadequate reimbursements, increasing product recalls and privacy concerns and safety issues associated with insulin pumps limit the growth of insulin pumps global market.

The insulin pumps global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Major players in the insulin pumps market include Medtronic PLC (Ireland), Insulet Corporation (U.S.), Tandem Diabetes Care Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Ypsomed Holdings AG (Switzerland), Zealand Pharma (Valeritas) (Denmark), SOOIL development (South Korea), Debiotech S.A. (France), and Microtech Medical, Inc (China).

1 EXECUTIVE SUMMARY
2 INTRODUCTION

2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY

2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS

3 MARKET ANALYSIS

3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET

3.3.1 DRIVERS AND OPPORTUNITIES

3.3.1.1 The global rise in the prevalence and incidence of diabetes
3.3.1.2 Increase in the use of insulin pumps in-home care settings and disadvantages of conventional methods over insulin pumps.
3.3.1.3 Increasing distribution agreements, partnerships and collaboration activities
3.3.1.4 Increase in product approvals

3.3.2 RESTRAINTS AND THREATS

3.3.2.1 High cost of the continuous subcutaneous insulin infusion therapy (CSII)
3.3.2.2 Inadequate reimbursement
3.3.2.3 Increased product recalls
3.3.2.4 Privacy concern and safety issues associated with insulin pumps
3.3.2.5 Stringent regulatory requirements for new products

3.4 REGULATORY AFFAIRS

3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION

3.4.1.1 ISO:9001: 2015 Quality Management System
3.4.1.2 ISO:13485 Medical Devices

3.4.2 U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 INDIA
3.4.6 CHINA
3.4.7 JAPAN

3.5 FUNDING
3.6 DEALS
3.7 PORTER’S FIVE FORCE ANALYSIS

3.7.1 THREAT OF NEW ENTRANTS
3.7.2 THREAT OF SUBSTITUTES
3.7.3 RIVALRY AMONG EXISTING COMPETITORS
3.7.4 BARGAINING POWER OF SUPPLIERS
3.7.5 BARGAINING POWER OF BUYERS

3.8 CLINICAL TRIALS
3.9 SUPPLY CHAIN ANALYSIS
3.10 MARKET SHARE ANALYSIS BY MAJOR PLAYERS

3.10.1 INSULIN PUMPS MARKET SHARE ANALYSIS

3.11 MARKET PENETRATION

3.11.1 GLOBAL TYPE 1 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS
3.11.2 GLOBAL TYPE 2 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS
3.11.3 N.A. TYPE 1 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS
3.11.4 N.A. TYPE 2 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS
3.11.5 E.U. TYPE 1 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS
3.11.6 E.U. TYPE 2 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS
3.11.7 APAC TYPE 1 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS
3.11.8 APAC TYPE 2 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS
3.11.9 ROW TYPE 1 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS
3.11.10 ROW TYPE 2 DIABETES INSULIN PUMP MARKET PENETRATION ANALYSIS

4 INSULIN PUMPS GLOBAL MARKET, BY PRODUCTS

4.1 INTRODUCTION
4.2 INSULIN PUMP DEVICES

4.2.1 TETHERED INSULIN PUMP
4.2.2 PATCH INSULIN PUMP

4.3 CONSUMABLES

5 INSULIN PUMPS GLOBAL MARKET, BY APPLICATION

5.1 INTRODUCTION
5.2 TYPE 1 DIABETES
5.3 TYPE 2 DIABETES

6 INSULIN PUMPS GLOBAL MARKET, BY UTILITY

6.1 INTRODUCTION
6.2 DURABLE INSULIN PUMP
6.3 DISPOSABLE INSULIN PUMP

6.3.1 PARTIALLY DISPOSABLE INSULIN PUMP
6.3.2 FULLY DISPOSABLE INSULIN PUMP

7 INSULIN PUMPS GLOBAL MARKET, BY END-USER

7.1 INTRODUCTION
7.2 HOSPITALS
7.3 AMBULATORY SURGICAL CENTERS
7.4 HOME HEALTHCARE
7.5 OTHERS

8 INSULIN PUMPS GLOBAL MARKET, BY REGION

8.1 INTRODUCTION
8.2 NORTH AMERICA

8.2.1 U.S.
8.2.2 REST OF NORTH AMERICA

8.3 EUROPE

8.3.1 GERMANY
8.3.2 FRANCE
8.3.3 ITALY
8.3.4 REST OF EUROPE

8.4 APAC

8.4.1 JAPAN
8.4.2 CHINA
8.4.3 INDIA
8.4.4 REST OF APAC

8.5 REST OF THE WORLD

8.5.1 BRAZIL
8.5.2 TURKEY
8.5.3 OTHERS

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION
9.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
9.3 NEW PRODUCT LAUNCH
9.4 APPROVAL
9.5 ACQUISITION
9.6 FUNDING
9.7 OTHERS

10 MAJOR COMPANIES

10.1 DEBIOTECH S.A.

10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS

10.2 INSULET CORPORATION

10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS

10.3 MEDTRONIC, PLC

10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS

10.4 MICROTECH MEDICAL, INC.

10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS

10.5 F. HOFFMANN-LA ROCHE AG.

10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS

10.6 SOOIL DEVELOPMENT CO. LTD.

10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS

10.7 TANDEM DIABETES CARE INC.

10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS

10.8 YPSOMED HOLDING AG.

10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS

10.9 ZEALAND PHARMA

10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS

10.10 ZHENGZHOU PHRAY TECHNOLOGY CO., LTD.

10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS

LIST OF TABLES

TABLE 1 INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN)
TABLE 2 TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION, BY REGION (2021)
TABLE 3 TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION, BY REGION (2021)
TABLE 4 INSULIN PUMPS GLOBAL MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 5 INSULIN PUMP DEVICES GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN)
TABLE 6 INSULIN PUMP DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE (2020-2028) ($MN)
TABLE 7 TETHERED INSULIN PUMP GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN)
TABLE 8 PATCH INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 9 CONSUMABLES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 10 FEATURES COMPARISON OF SOME OF THE CURRENTLY MARKETED INSULIN PUMPS
TABLE 11 INSULIN PUMPS GLOBAL MARKET REVENUE, BY APPLICATION (2020-2028) ($MN)
TABLE 12 TYPE 1 DIABETES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 13 TYPE 2 DIABETES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 14 INSULIN PUMPS GLOBAL MARKET REVENUE, BY PUMP UTILITY (2020-2028) ($MN)
TABLE 15 DURABLE PUMP GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 16 DISPOSABLE PUMP GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 17 DISPOSABLE PUMP GLOBAL MARKET REVENUE, BY PUMP TYPE (2020-2028) ($MN)
TABLE 18 PARTIALLY DISPOSABLE PUMP GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 19 FULLY DISPOSABLE PUMP GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 20 INSULIN PUMPS GLOBAL MARKET REVENUE, BY END-USER
TABLE 21 HOSPITAL GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 22 AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 23 HOME HEALTHCARE GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 24 OTHER END-USER GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 25 INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN)
TABLE 26 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 27 NORTH AMERICA INSULIN PUMP DEVICES MARKET REVENUE, BY PRODUCT TYPE (2020-2028) ($MN)
TABLE 28 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY APPLICATION (2020-2028) ($MN)
TABLE 29 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY (2020-2028) ($MN)
TABLE 30 NORTH AMERICA DISPOSABLE PUMPS MARKET REVENUE, BY PUMP TYPE (2020-2028) ($MN)
TABLE 31 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY END-USER (2020-2028) ($MN)
TABLE 32 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY COUNTRY (2020-2028) ($MN)
TABLE 33 EUROPE INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 34 EUROPE INSULIN PUMP DEVICES MARKET REVENUE, BY PRODUCT TYPE (2020-2028) ($MN)
TABLE 35 EUROPE INSULIN PUMPS MARKET REVENUE, BY APPLICATION (2020-2028) ($MN)
TABLE 36 EUROPE INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY (2020-2028) ($MN)
TABLE 37 EUROPE DISPOLSABLE PUMPS MARKET REVENUE, BY PUMP TYPE (2020-2028) ($MN)
TABLE 38 EUROPE INSULIN PUMPS MARKET REVENUE, BY END-USER (2020-2028) ($MN)
TABLE 39 EUROPE INSULIN PUMPS MARKET REVENUE, BY COUNTRY (2020-2028) ($MN)
TABLE 40 APAC INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 41 APAC INSULIN PUMPS MARKET REVENUE, BY PRODUCT TYPE (2020-2028) ($MN)
TABLE 42 APAC INSULIN PUMPS MARKET REVENUE, BY APPLICATION (2020-2028) ($MN)
TABLE 43 APAC INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY (2020-2028) ($MN)
TABLE 44 APAC DISPOSABLE PUMPS MARKET REVENUE, BY PUMP TYPE (2020-2028) ($MN)
TABLE 45 APAC INSULIN PUMPS MARKET REVENUE, BY END-USER (2020-2028) ($MN)
TABLE 46 APAC INSULIN PUMPS MARKET REVENUE, BY COUNTRY (2020-2028) ($MN)
TABLE 47 ROW INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 48 ROW INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 49 ROW INSULIN PUMPS MARKET REVENUE, BY APPLICATION (2020-2028) ($MN)
TABLE 50 ROW INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY (2020-2028) ($MN)
TABLE 51 ROW DISPOSABLE PUMPS MARKET REVENUE, BY PUMP TYPE (2020-2028) ($MN)
TABLE 52 ROW INSULIN PUMPS MARKET REVENUE, BY END-USER (2020-2028) ($MN)
TABLE 53 ROW INSULIN PUMPS MARKET REVENUE, BY COUNTRY (2020-2028) ($MN)
TABLE 54 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2020-2021)
TABLE 55 NEW PRODUCT LAUNCH (2020-2021)
TABLE 56 APPROVALS (2020-2021)
TABLE 57 ACQUISITION (2020-2021)
TABLE 58 FUNDING (2020-2021)
TABLE 59 OTHERS (2020-2021)
TABLE 60 INSULET CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2019-2021 (Q2)) ($MN)
TABLE 61 INSULET CORPORATION: TOTAL REVENUE, BY SEGMENT, (2019-2021 (Q2)) ($MN)
TABLE 62 INSULET CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021 (Q2)) ($MN)
TABLE 63 MEDTRONIC PLC: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) ($MN)
TABLE 64 MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENT, (2019-2021) ($MN)
TABLE 65 MEDTRONIC PLC: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) ($MN)
TABLE 66 F. HOFFMANN-LA ROCHE AG: TOTAL REVENUE AND R&D EXPENSES, (2019-2021(Q2)) ($MN)
TABLE 67 F. HOFFMANN-LA ROCHE AG: TOTAL REVENUE, BY SEGMENT, (2019-2021 (Q2)) ($MN)
TABLE 68 F. HOFFMANN-LA ROCHE AG: DIAGNOSTIC REVENUE, BY SUB-SEGMENT, (2019-2021) (Q2) ($MN)
TABLE 69 F. HOFFMANN-LA ROCHE AG: DIAGNOSTIC DIVISION TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) (Q2) ($MN)
TABLE 70 TANDEM DIABETES CARE INC: TOTAL REVENUE AND R&D EXPENSES, (2019-2021 (Q2)) ($MN)
TABLE 71 TANDEM DIABETES CARE INC: TOTAL REVENUE, BY SEGMENT, (2019-2021 (Q2)) ($MN)
TABLE 72 TANDEM DIABETES CARE INC: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021 (Q2)) ($MN)
TABLE 73 YPSOMED HOLDINGS AG: TOTAL REVENUE AND R&D EXPENSES, (2018-2020) ($MN)
TABLE 74 YPSOMED HOLDINGS AG: TOTAL REVENUE, BY SEGMENT, (2018-2020) ($MN)
TABLE 75 YPSOMED HOLDINGS AG: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
TABLE 76 ZEALAND PHARMA: TOTAL REVENUE AND R&D EXPENSES, (2019-2021)(Q1) ($MN)

LIST OF FIGURES

FIGURE 1 INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: INSULIN PUMPS GLOBAL MARKET
FIGURE 3 INSULIN PUMPS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 INSULIN PUMPS GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 INSULIN PUMPS GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 INSULIN PUMPS GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 INSULIN PUMPS GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 9 CLINICAL TRIALS OF INSULIN PUMPS
FIGURE 10 INSULIN PUMPS GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 11 INSULIN PUMPS GLOBAL MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2021 (%)
FIGURE 12 GLOBAL TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 13 GLOBAL TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 14 N.A. TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 15 N.A. TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 16 E.U. TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 17 E.U. TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 18 APAC TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 19 APAC TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 20 ROW TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 21 ROW TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 22 INSULIN PUMPS GLOBAL MARKET REVENUE, BY PRODUCTS AND PRODUCT TYPE (2021) ($ MN)
FIGURE 23 CONSUMABLES GLOBAL MARKET SHARE, BY REGION (2021 V/S 2028) (%)
FIGURE 24 INSULIN PUMPS GLOBAL MARKET SHARE, BY APPLICATION (2021 V/S 2028) (%)
FIGURE 25 INSULIN PUMP GLOBAL MARKET SHARE, BY PUMP UTILITY, (2021 V/S 2028) (%)
FIGURE 26 DURABLE PUMP GLOBAL MARKET SHARE, BY REGION, (2021 V/S 2028) (%)
FIGURE 27 DISPOSABLE PUMP GLOBAL MARKET SHARE, BY PUMP TYPE, (2021 V/S 2028) (%)
FIGURE 28 INSULIN PUMPS GLOBAL MARKET SHARE, BY END-USER (2021 V/S 2028) (%)
FIGURE 29 HOSPITALS GLOBAL MARKET SHARE, BY REGION, (2021 V/S 2028) (%)
FIGURE 30 HOME HEALTHCARE GLOBAL MARKET SHARE, BY REGION (2021 V/S 2028) (%)
FIGURE 31 OTHER END-USER GLOBAL MARKET SHARE, BY REGION, (2021 V/S 2028) (%)
FIGURE 32 INSULIN PUMPS GLOBAL MARKET REVENUE, BY REGION (2021 V/S 2028) (%)
FIGURE 33 INSULIN PUMPS GLOBAL MARKET SHARE, BY REGIONAL MARKET REVENUE (2021) (%) ($MN)
FIGURE 34 NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND PRODUCT TYPE (2021) (%)
FIGURE 35 NORTH AMERICA INSULIN PUMPS MARKET SHARE, BY APPLICATION (2021 V/S 2028) (%)
FIGURE 36 NORTH AMERICA INSULIN PUMPS MARKET SHARE, BY PUMP UTILITY, (2021 V/S 2028) (%)
FIGURE 37 NORTH AMERICA INSULIN PUMPS MARKET SHARE, BY END-USER (2021 V/S 2028) (%)
FIGURE 38 NORTH AMERICA INSULIN PUMPS MARKET SHARE, BY COUNTRY (2021 V/S 2028) (%)
FIGURE 39 U.S. INSULIN PUMPS MARKET REVENUE, BY PRODUCT AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 40 U.S. INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USER (2021 V/S 2028) ($MN)
FIGURE 41 U.S. TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 42 U.S. TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 43 REST OF NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY PRODUCT AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 44 REST NORTH AMERICA INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USER (2021 V/S 2028) ($MN)
FIGURE 45 CANADA TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 46 CANADA TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 47 MEXICO TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 48 MEXICO TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 49 EUROPE INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND PRODUCTS TYPE (2021) (%)
FIGURE 50 EUROPE INSULIN PUMPS MARKET SHARE, BY PUMP UTILITY, (2021 V/S 2028) (%)
FIGURE 51 EUROPE DISPOLSABLE PUMPS MARKET SHARE, BY PUMP TYPE, (2021 V/S 2028) (%)
FIGURE 52 EUROPE INSULIN PUMPS MARKET SHARE, BY END-USER (2021 V/S 2028) (%)
FIGURE 53 EUROPE INSULIN PUMPS MARKET SHARE, BY COUNTRY (2021 V/S 2028) (%)
FIGURE 54 GERMANY INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 55 GERMANY INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USERS (2021 V/S 2028) ($MN)
FIGURE 56 GERMANY TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 57 GERMANY TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 58 FRANCE INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 59 FRANCE INSULIN PUMPS MARKET REVENUE, BY APPLICATION (2021 V/S 2028) ($MN)
FIGURE 60 FRANCE TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 61 FRANCE TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 62 ITALY INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 63 ITALY INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USERS (2021 V/S 2028) ($MN)
FIGURE 64 ITALY TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 65 ITALY TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 66 REST OF EUROPE INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 67 REST OF EUROPE INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USERS (2021 V/S 2028) ($MN)
FIGURE 68 REST OF EUROPE TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 69 REST OF EUROPE TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 70 APAC INSULIN PUMPS MARKET REVENUE, BY PRODUCT AND PRODUCT TYPE (2021) ($MN)
FIGURE 71 APAC INSULIN PUMPS MARKET SHARE, BY APPLICATION (2021 V/S 2028) (%)
FIGURE 72 APAC INSULIN PUMPS MARKET SHARE, BY PUMP UTILITY, (2021 V/S 2028) (%)
FIGURE 73 APAC DISPOSABLE PUMPS MARKET SHARE, BY PUMP TYPE, (2021 V/S 2028) (%)
FIGURE 74 APAC INSULIN PUMPS MARKET SHARE, BY END-USER (2021 V/S 2028) (%)
FIGURE 75 APAC INSULIN PUMPS MARKET SHARE, BY COUNTRY (2021 V/S 2028) (%)
FIGURE 76 JAPAN INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 77 JAPAN INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USERS (2021 V/S 2028) ($MN)
FIGURE 78 JAPAN TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 79 JAPAN TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 80 CHINA INSULIN PUMPS MARKET REVENUE, BY PRODUCT AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 81 CHINA INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USERS (2021 V/S 2028) ($MN)
FIGURE 82 CHINA TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 83 CHINA TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 84 INDIA INSULIN PUMPS MARKET REVENUE, BY PRODUCT AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 85 INDIA INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USER (2021 V/S 2028) ($MN)
FIGURE 86 INDIA TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 87 INDIA TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 88 REST OF APAC INSULIN PUMPS MARKET REVENUE, BY PRODUCT AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 89 REST OF APAC INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USERS (2021 V/S 2028) ($MN)
FIGURE 90 REST OF APAC TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 91 REST OF APAC TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 92 ROW INSULIN PUMPS MARKET REVENUE, BY PRODUCTS (2021) ($MN)
FIGURE 93 ROW INSULIN PUMPS MARKET SHARE, BY APPLICATION (2021 V/S 2028) (%)
FIGURE 94 ROW INSULIN PUMPS GLOBAL MARKET SHARE, BY PUMP UTILITY, (2021 V/S 2028) (%)
FIGURE 95 ROW DISPOSABLE PUMPS GLOBAL MARKET SHARE, BY PUMP TYPE, (2021 V/S 2028) (%)
FIGURE 96 ROW INSULIN PUMPS MARKET SHARE, BY END-USER (2021 V/S 2028) (%)
FIGURE 97 ROW INSULIN PUMPS MARKET SHARE, BY COUNTRY (2021 V/S 2028) (%)
FIGURE 98 BRAZIL INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 99 BRAZIL INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 100 BRAZIL TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 101 BRAZIL TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 102 TURKEY INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 103 TURKEY INSULIN PUMPS MARKET REVENUE, BY PUMP UTILITY AND END-USERS (2021 V/S 2028) ($MN)
FIGURE 104 TURKEY TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 105 TURKEY TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 106 OTHERS INSULIN PUMPS MARKET REVENUE, BY PRODUCTS AND APPLICATION (2021 V/S 2028) ($MN)
FIGURE 107 OTHERS INSULIN PUMPS MARKET REVENUE, BY PUMP UTILIY AND END-USER (2021 V/S 2028) ($MN)
FIGURE 108 OTHERS TYPE 1 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 109 OTHERS TYPE 2 DIABETES INSULIN PUMPS MARKET PENETRATION (2021)
FIGURE 110 KEY GROWTH STRATEGIES (2020-2021)
FIGURE 111 SWOT: DEBIOTECH S.A.
FIGURE 112 SWOT: INSULET CORPORATION
FIGURE 113 SWOT: MEDTRONIC, PLC
FIGURE 114 SWOT: MICROTECH MEDICAL INC
FIGURE 115 SWOT: F. HOFFMANN-LA ROCHE AG.
FIGURE 116 SWOT: SOOIL DEVELOPMENT CO. LTD.
FIGURE 117 SWOT: TANDEM DIABETES CARE INC
FIGURE 118 SWOT: YPSOMED HOLDINGS AG
FIGURE 119 SWOT: ZEALAND PHARMA
FIGURE 120 SWOT: ZHENGZHOU PHRAY TECHNOLOGY CO., LTD

LIST OF COMPANIES MENTIONED IN THE REPORT

1 CEQUR SA
2 DEBIOTECH S.A.
3 EOFLOW
4 F. HOFFMANN LA ROCHE AG
5 INSULET CORPORATION
6 JIANGSU DELFU MEDICAL DEVICE CO., LTD.
7 LENOMED MEDICAL
8 MEDTRONIC, PLC
9 MEDTRUM TECHNOLOGIES
10 MEDZER
11 MICROPORT SCIENTIFIC
12 MICROTECH MEDICAL, INC.
13 SOOIL DEVELOPMENT
14 TANDEM DIABETES CARE
15 TERUMO CORPORATION
16 VICENTRA B.V.
17 WUXI APEX MEDICAL
18 YPSOMED AG
19 ZEALAND PHARMA (VALERITAS)
20 ZHENGZHOU PHRAY TECHNOLOGY CO., LTD.

Insulin Pumps Global Market – Forecast To 2028

LIST OF TABLES

LIST OF FIGURES

LIST OF COMPANIES MENTIONED IN THE REPORT

IQ4I HEALTHCARE REPORTS

about IQ4I

Get in Touch

IQ4I Quality Accredit Certificate

Subscribe to Newsletter

Medical Devices

Insulin Pumps Global Market – Forecast To 2028

Insulin Pumps Global Market – Forecast To 2028

LIST OF TABLES

LIST OF FIGURES

LIST OF COMPANIES MENTIONED IN THE REPORT

IQ4I HEALTHCARE REPORTS